Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT05386108
Title Study of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer (ELECTRA)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Stemline Therapeutics, Inc.

Her2-receptor negative breast cancer



Abemaciclib + Elacestrant

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.